Literature DB >> 31430258

Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.

Britta Höchsmann1,2, Yoshiko Murakami3,4, Makiko Osato3,5, Alexej Knaus6, Michi Kawamoto7, Norimitsu Inoue8, Tetsuya Hirata3, Shogo Murata3,9, Markus Anliker1, Thomas Eggermann10, Marten Jäger11, Ricarda Floettmann11, Alexander Höllein12, Sho Murase7, Yasutaka Ueda5, Jun-Ichi Nishimura5, Yuzuru Kanakura5, Nobuo Kohara7, Hubert Schrezenmeier1, Peter M Krawitz6, Taroh Kinoshita3,4.   

Abstract

Patients with paroxysmal nocturnal hemoglobinuria (PNH) have a clonal population of blood cells deficient in glycosylphosphatidylinositol-anchored (GPI-anchored) proteins, resulting from a mutation in the X-linked gene PIGA. Here we report on a set of patients in whom PNH results instead from biallelic mutation of PIGT on chromosome 20. These PIGT-PNH patients have clinically typical PNH, but they have in addition prominent autoinflammatory features, including recurrent attacks of aseptic meningitis. In all these patients we find a germ-line point mutation in one PIGT allele, whereas the other PIGT allele is removed by somatic deletion of a 20q region comprising maternally imprinted genes implicated in myeloproliferative syndromes. Unlike in PIGA-PNH cells, GPI is synthesized in PIGT-PNH cells and, since its attachment to proteins is blocked, free GPI is expressed on the cell surface. From studies of patients' leukocytes and of PIGT-KO THP-1 cells we show that, through increased IL-1β secretion, activation of the lectin pathway of complement and generation of C5b-9 complexes, free GPI is the agent of autoinflammation. Eculizumab treatment abrogates not only intravascular hemolysis, but also autoinflammation. Thus, PIGT-PNH differs from PIGA-PNH both in the mechanism of clonal expansion and in clinical manifestations.

Entities:  

Keywords:  Complement; Glycobiology; Hematology; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 31430258      PMCID: PMC6877298          DOI: 10.1172/JCI123501

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  Cytogenetic abnormalities in paroxysmal nocturnal haemoglobinuria usually occur in haematopoietic cells that are glycosylphosphatidylinositol-anchored protein (GPI-AP) positive.

Authors:  Elaine M Sloand; Monika Fuhrer; Keyvan Keyvanfar; Lori Mainwaring; Jaroslaw Maciejewski; Yu Wang; Sarah Johnson; A John Barrett; Neal S Young
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

Review 2.  The lectin-complement pathway--its role in innate immunity and evolution.

Authors:  Teizo Fujita; Misao Matsushita; Yuichi Endo
Journal:  Immunol Rev       Date:  2004-04       Impact factor: 12.988

Review 3.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

4.  Expression cloning of PIG-L, a candidate N-acetylglucosaminyl-phosphatidylinositol deacetylase.

Authors:  N Nakamura; N Inoue; R Watanabe; M Takahashi; J Takeda; V L Stevens; T Kinoshita
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

5.  Novel compound heterozygous PIGT mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3.

Authors:  Mitsuko Nakashima; Hirofumi Kashii; Yoshiko Murakami; Mitsuhiro Kato; Yoshinori Tsurusaki; Noriko Miyake; Masaya Kubota; Taroh Kinoshita; Hirotomo Saitsu; Naomichi Matsumoto
Journal:  Neurogenetics       Date:  2014-06-08       Impact factor: 2.660

6.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

7.  Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients.

Authors:  Megumu Saito; Ryuta Nishikomori; Naotomo Kambe; Akihiro Fujisawa; Hideaki Tanizaki; Kyoko Takeichi; Tomoyuki Imagawa; Tomoko Iehara; Hidetoshi Takada; Tadashi Matsubayashi; Hiroshi Tanaka; Hisashi Kawashima; Kiyoshi Kawakami; Shinji Kagami; Ikuo Okafuji; Takakazu Yoshioka; Souichi Adachi; Toshio Heike; Yoshiki Miyachi; Tatsutoshi Nakahata
Journal:  Blood       Date:  2007-12-06       Impact factor: 22.113

Review 8.  Primitive complement system--recognition and activation.

Authors:  Teizo Fujita; Yuichi Endo; Masaru Nonaka
Journal:  Mol Immunol       Date:  2004-06       Impact factor: 4.407

9.  Human PIG-U and yeast Cdc91p are the fifth subunit of GPI transamidase that attaches GPI-anchors to proteins.

Authors:  Yeongjin Hong; Kazuhito Ohishi; Ji Young Kang; Satoshi Tanaka; Norimitsu Inoue; Jun-ichi Nishimura; Yusuke Maeda; Taroh Kinoshita
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

10.  Identification of a Golgi GPI-N-acetylgalactosamine transferase with tandem transmembrane regions in the catalytic domain.

Authors:  Tetsuya Hirata; Sushil K Mishra; Shota Nakamura; Kazunobu Saito; Daisuke Motooka; Yoko Takada; Noriyuki Kanzawa; Yoshiko Murakami; Yusuke Maeda; Morihisa Fujita; Yoshiki Yamaguchi; Taroh Kinoshita
Journal:  Nat Commun       Date:  2018-01-26       Impact factor: 14.919

View more
  12 in total

1.  Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency.

Authors:  Robert A Brodsky
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

2.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

3.  Prevention of intrauterine fetal growth restriction by administrating C1q/TNF-related protein 6, a specific inhibitor of the alternative complement pathway.

Authors:  Mayu Kurokawa; Ai Takeshita; Shu Hashimoto; Masayasu Koyama; Yoshiharu Morimoto; Daisuke Tachibana
Journal:  J Assist Reprod Genet       Date:  2022-07-30       Impact factor: 3.357

4.  Allogeneic stem cell transplantation-A curative treatment for paroxysmal nocturnal hemoglobinuria with PIGT mutation: A case report.

Authors:  Laurence Schenone; Anne-Béatrice Notarantonio; Véronique Latger-Cannard; Veronique Fremeaux-Bacchi; Marcelo De Carvalho-Bittencourt; Marie-Thérèse Rubio; Marc Muller; Maud D'Aveni
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

Review 5.  The inflammasomes: crosstalk between innate immunity and hematology.

Authors:  Valéria de Freitas Dutra; Vinicius Nunes Cordeiro Leal; Alessandra Pontillo
Journal:  Inflamm Res       Date:  2022-10-20       Impact factor: 6.986

6.  Paroxysmal nocturnal hemoglobinuria caused by CN-LOH of constitutional PIGB mutation and 70-kbp microdeletion on 15q.

Authors:  Saskia Langemeijer; Charlotte Schaap; Frank Preijers; Joop H Jansen; Nicole Blijlevens; Norimitsu Inoue; Petra Muus; Taroh Kinoshita; Yoshiko Murakami
Journal:  Blood Adv       Date:  2020-11-24

7.  Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Carmelo Gurnari; Simona Pagliuca; Bhumika J Patel; Hassan Awada; Sunisa Kongkiatkamon; Laila Terkawi; Misam Zawit; Seth Corey; Alan E Lichtin; Hetty E Carraway; Adam Wahida; Valeria Visconte; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2021-01-22       Impact factor: 12.883

8.  Classical complement and inflammasome activation converge in CD14highCD16- monocytes in HIV associated TB-immune reconstitution inflammatory syndrome.

Authors:  Silvia Lucena Lage; Chun-Shu Wong; Eduardo Pinheiro Amaral; Daniel Sturdevant; Denise C Hsu; Adam Rupert; Eleanor M P Wilson; S Sonia Qasba; Nuha Sultana Naqvi; Elizabeth Laidlaw; Andrea Lisco; Maura Manion; Irini Sereti
Journal:  PLoS Pathog       Date:  2021-03-31       Impact factor: 6.823

Review 9.  Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs.

Authors:  Marcelo T Bozza; Viktória Jeney
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

Review 10.  Biosynthesis and biology of mammalian GPI-anchored proteins.

Authors:  Taroh Kinoshita
Journal:  Open Biol       Date:  2020-03-11       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.